Related Experiment Video
Updated: Jun 16, 2026
06:58
Frailty Assessment in an Aging Mouse Model
Published on: September 23, 2025
Frailty and heart failure: Clinical impact, biomarkers, and phenotypic differences
Husam Katib1, Naushira Pandya2, Vincent Guida2
1HCA Florida Aventura Hospital, USA.
The American Journal of the Medical Sciences
|June 13, 2026
Summary
Frailty significantly impacts heart failure (HF) patients, predicting worse outcomes. Tailored management strategies considering HF phenotypes are crucial for improving care and quality of life in frail individuals.
Area of Science:
- Geriatric Medicine
- Cardiology
- Clinical Research
Background:
- Frailty is a geriatric syndrome of reduced physiologic reserve, common in heart failure (HF) patients.
- It independently predicts adverse outcomes like hospitalization, mortality, and reduced quality of life.
- The Fried Frailty Phenotype includes weight loss, exhaustion, weakness, slow walking speed, and low physical activity.
Purpose of the Study:
- To review the intricate relationship between frailty and heart failure.
- To examine pathophysiology, clinical outcomes, biomarkers, and therapeutic approaches.
- To emphasize phenotype-specific management for heart failure with reduced (HFrEF), preserved (HFpEF), and mildly reduced (HFmrEF) ejection fraction.
Main Methods:
- Literature review focusing on frailty and heart failure.
- Analysis of pathophysiology, clinical outcomes, and biomarkers.
- Discussion of therapeutic considerations and future research directions.
Main Results:
- Frailty is highly prevalent in HF and linked to poor prognosis.
- Differences in frailty impact across HF phenotypes (HFrEF, HFpEF, HFmrEF) necessitate tailored interventions.
- Emerging biomarkers like stress hyperglycemia ratio (SHR) show promise, particularly in HFpEF.
Conclusions:
- Frailty assessment and management are vital components of comprehensive heart failure care.
- Phenotype-specific strategies are essential for optimizing treatment outcomes in frail HF patients.
- Further research is needed to integrate frailty assessment into routine HF management and explore novel biomarkers.
Related Concept Videos
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...